Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BXDC | HOPE |
|---|---|---|
| Price | $17.22 | $13.57 |
| Change today | ▼ 0.29% | ▼ 0.80% |
| Market cap | $1.73B | $1.73B |
| Return, 3 months | -17.5% | +2.7% |
| Return, year to date | – | +27.9% |
| Return, 1 year | – | +27.7% |
| P/E (TTM) | -410.0 | 13.4 |
| P/B | 0.9 | 0.8 |
| P/E percentile vs own 5y | 93rd | – |
| Dividend yield | – | 4.13% |
| Revenue growth (YoY, latest qtr) | – | +56.4% |
| Net profit growth (YoY) | – | +233.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 22.2% |
| Return on equity | – | 5.7% |
| Analyst target vs. price | +35.5% | +14.2% |
| Analyst buy share | 38% | 33% |
| RSI (14) | 24 | 44 |
| 30-day volatility | 26.1% | 15.7% |
| Max drawdown, 1 year | -22.9% | -14.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
